Collectively, lncRNA BCAR4 promotes ESCC tumorigenesis via regulating p53/p21 signaling pathway and plays as a new prognostic biomarker therapeutic target for ESCC. This evidence concerns the gene BCAR4 and esophageal squamous cell carcinoma.